VarmX

Leiden, Netherlands · Founded 2016 · Acquired/Merged (Operating Subsidiary)

Manufacturer of therapeutic drugs designed to restore blood clotting in patients experiencing bleeding events. VarmX is based in Leiden, Netherlands and was founded in 2016. Its last known valuation is $505 million (Sep 2025). It has raised $103 million.

Last price · $/share
—
Implied valuation
$505.0M
Total raised
$102.5M
Last round
—

Who backs VarmX?

13 investors
InvestorType
EQT Life SciencesVenture capital
InnovationQuarterOther
MaasInvestPE / buyout
BioGeneration Ventures—
CSL—
European Innovation Council (Belgium)—
Inkef—
Leiden University—
Lundbeckfonden BioCapital—
Mibiton—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

VarmX investors

13 investors are on record for VarmX, including EQT Life Sciences, InnovationQuarter, MaasInvest and BioGeneration Ventures.

Free account
More of VarmX with a free account
  • ·The complete investor list: 13 names
  • ·Watch VarmX: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like VarmX. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View